CBT - Cabot Corporation
NYSE
->
Basic Materials
->
Specialty Chemicals
Boston,
United States
Type: Equity
CBT price evolution
CBT
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jul 2023 | 1 May 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $244 | $238 | $220 | $205 |
| Short term investments | ||||
| Net receivables | $726 | $695 | $688 | $767 |
| Inventory | $617 | $585 | $592 | $625 |
| Total current assets | $1692 | $1626 | $1602 | $1742 |
| Long term investments | $21 | $20 | $19 | $22 |
| Property, plant & equipment | $1444 | $1412 | $1364 | $1353 |
| Goodwill & intangible assets | $199 | $194 | $199 | $199 |
| Total noncurrent assets | $2003 | $1978 | $1785 | $1777 |
| Total investments | $21 | $20 | $19 | $22 |
| Total assets | $3695 | $3604 | $3387 | $3519 |
| Current liabilities | ||||
| Accounts payable | $585 | $600 | $568 | $609 |
| Deferred revenue | ||||
| Short long term debt | $214 | $182 | $143 | $266 |
| Total current liabilities | $830 | $822 | $738 | $904 |
| Long term debt | $1098 | $1094 | $1093 | $1094 |
| Total noncurrent liabilities | $1390 | $1375 | $1383 | $1383 |
| Total debt | $1312 | $1276 | $1236 | $1360 |
| Total liabilities | $2220 | $2197 | $2121 | $2287 |
| Shareholders' equity | ||||
| Retained earnings | $1582 | $1574 | $1407 | $1360 |
| Other shareholder equity | -$305 | -$362 | -$329 | -$314 |
| Total shareholder equity | $1329 | $1264 | $1131 | $1099 |
| (in millions $) | 31 Jan 2024 | 30 Oct 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $238 | $206 | $168 | $151 |
| Short term investments | ||||
| Net receivables | $695 | $836 | $645 | $418 |
| Inventory | $585 | $664 | $523 | $359 |
| Total current assets | $1626 | $1820 | $1425 | $978 |
| Long term investments | $20 | $20 | $40 | $39 |
| Property, plant & equipment | $1412 | $1270 | $1376 | $1314 |
| Goodwill & intangible assets | $194 | $192 | $240 | $237 |
| Total noncurrent assets | $1978 | $1705 | $1881 | $1803 |
| Total investments | $20 | $20 | $40 | $39 |
| Total assets | $3604 | $3525 | $3306 | $2781 |
| Current liabilities | ||||
| Accounts payable | $600 | $707 | $667 | $488 |
| Deferred revenue | ||||
| Short long term debt | $182 | $354 | $445 | $21 |
| Total current liabilities | $822 | $1105 | $1147 | $529 |
| Long term debt | $1094 | $1089 | $717 | $1094 |
| Total noncurrent liabilities | $1375 | $1388 | $1069 | $1438 |
| Total debt | $1276 | $1443 | $1162 | $1115 |
| Total liabilities | $2197 | $2627 | $2216 | $1967 |
| Shareholders' equity | ||||
| Retained earnings | $1574 | $1284 | $1159 | $989 |
| Other shareholder equity | -$362 | -$439 | -$289 | -$351 |
| Total shareholder equity | $1264 | $898 | $947 | $691 |
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jul 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $965 | $1033 | ||
| Cost of revenue | $740 | $823 | ||
| Gross Profit | $225 | $210 | ||
| Operating activities | ||||
| Research & development | $14 | $15 | ||
| Selling, general & administrative | $69 | $66 | ||
| Total operating expenses | $83 | $81 | ||
| Operating income | $142 | $129 | ||
| Income from continuing operations | ||||
| EBIT | $137 | $127 | ||
| Income tax expense | -$118 | $29 | ||
| Interest expense | $21 | $23 | ||
| Net income | ||||
| Net income | $234 | $75 | ||
| Income (for common shares) | $234 | $75 | ||
| (in millions $) | 31 Jan 2024 | 30 Oct 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4321 | $2614 | ||
| Cost of revenue | $2114 | |||
| Gross Profit | $885 | $500 | ||
| Operating activities | ||||
| Research & development | $57 | |||
| Selling, general & administrative | $292 | |||
| Total operating expenses | $313 | $479 | ||
| Operating income | $21 | |||
| Income from continuing operations | ||||
| EBIT | $6 | |||
| Income tax expense | $102 | $191 | ||
| Interest expense | -$45 | $53 | ||
| Net income | ||||
| Net income | $209 | -$238 | ||
| Income (for common shares) | -$238 | |||
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $50 | $234 | $82 | $75 |
| Operating activities | ||||
| Depreciation | $41 | $37 | $36 | $36 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $6 | $5 | $3 | $6 |
| Total cash flows from operations | $105 | $138 | $243 | $162 |
| Investing activities | ||||
| Capital expenditures | -$54 | -$78 | -$80 | -$51 |
| Investments | ||||
| Total cash flows from investing | -$54 | -$75 | -$75 | -$47 |
| Financing activities | ||||
| Dividends paid | -$22 | -$23 | -$23 | -$21 |
| Sale and purchase of stock | -$26 | -$50 | -$15 | -$15 |
| Net borrowings | $31 | $42 | -$123 | -$55 |
| Total cash flows from financing | -$29 | -$32 | -$161 | -$118 |
| Effect of exchange rate | -$16 | -$13 | $8 | $18 |
| Change in cash and equivalents | $6 | $18 | $15 | $15 |
| (in millions $) | 31 Dec 2023 | 30 Oct 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $445 | $250 | -$238 | |
| Operating activities | ||||
| Depreciation | $144 | $160 | $158 | |
| Business acquisitions & disposals | $6 | -$92 | ||
| Stock-based compensation | $20 | $21 | $9 | |
| Total cash flows from operations | $595 | $257 | $377 | |
| Investing activities | ||||
| Capital expenditures | -$237 | -$195 | -$200 | |
| Investments | ||||
| Total cash flows from investing | -$214 | -$118 | -$186 | -$288 |
| Financing activities | ||||
| Dividends paid | -$88 | -$84 | -$80 | -$80 |
| Sale and purchase of stock | -$94 | $3 | -$41 | |
| Net borrowings | -$179 | $36 | $15 | |
| Total cash flows from financing | -$403 | $145 | -$60 | -$132 |
| Effect of exchange rate | $54 | -$91 | $8 | $25 |
| Change in cash and equivalents | $32 | $36 | $19 | -$18 |
News
|
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Zacks via Yahoo Finance
10 May 2024
|
|
Cabot (NYSE:CBT) Is Increasing Its Dividend To $0.43
Simply Wall St. via Yahoo Finance
10 May 2024
|
|
Cabot (NYSE:CBT) Reaches New 52-Week High Following Better-Than-Expected Earnings
ETF DAILY NEWS
9 May 2024
|
|
UBS Group Increases Cabot (NYSE:CBT) Price Target to $103.00
ETF DAILY NEWS
9 May 2024
|
|
Cabot Corporation (NYSE:CBT) Q2 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance
8 May 2024
|
|
Earnings call: Cabot Corporation reports strong Q2 results, raises EPS guidance By Investing.com
Investing.com
7 May 2024
|
|
Cabot's (CBT) Earnings Top Estimates in Q2, Revenues Lag
Zacks via Yahoo Finance
7 May 2024
|
|
Cabot Corporation raises dividend to $0.43 per share By Investing.com
Investing.com
7 May 2024
|
|
Analysts Set Cabot Co. (NYSE:CBT) Target Price at $87.67
ETF DAILY NEWS
23 Apr 2024
|
|
Cabot (CBT) Chosen for $5M DOE Grant to Aid Hydrogen Economy
Zacks via Yahoo Finance
22 Apr 2024
|
Fundamentals
| Market cap | $5.65B |
|---|---|
| Enterprise value | $6.72B |
| Shares outstanding | 55.42M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 3.46 |
| Book/Share | 29.48 |
| Cash/Share | 4.40 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.74 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.04 |
| Quick ratio | 1.30 |